XML 41 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity
 9 Months Ended
Sep. 30, 2013
Equity [Abstract]  
Equity
Note 7 – Equity
 
Approval of the 2013 Stock Plan
 
The Board approved the Company’s 2013 Stock Plan.  The expiration date of the plan is September  9, 2023  and the total number of underlying shares of the Company’s common stock available for grant to employees, directors and consultants of the Company under the plan is 2,750,000 shares.
Approval of the Equity Incentive Plan
 
The Board approved the Company’s 2013 Equity Incentive Plan. The expiration date of the plan is September  9, 2023  and the total number of shares of the Company’s common stock available for grant to employees, directors and consultants of the Company under the plan is 450,000 shares.
 
Options
 
The following is a summary of option activities:
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
Weighted
 
Remaining
 
Aggregate
 
 
Number of
 
Average
 
Contractual
 
Intrinsic
 
 
Units
 
Exercise Price
 
Term (in years)
 
Value
 
 
 
 
 
 
 
 
 
 
Outstanding, December 31, 2012
  2,330,134  $0.96   8.91  $685,800 
                 
Cancellation
  (49,950)            
 
                
Outstanding, September 30, 2013
  2,280,184  $0.95   8.17  $1,609,035 
 
All options issued and outstanding are being amortized over their respective vesting periods. The unrecognized compensation expense at September 30, 2013 was $1,014,474.
 
Warrants
The following is a summary of warrant activities:
 
        
Weighted
    
        
Average
    
     
Weighted
  
Remaining
  
Aggregate
 
  
Number of
  
Average
  
Contractual
  
Intrinsic
 
  
Units
  
Exercise Price
  
Term (in years)
  
Value
 
  
 
  
 
     
 
 
Outstanding, December 31, 2012
  12,770,636  $0.97   4.48  $  6,114,768 
Warrants exercised
  (2,304,910) $1.65         
Warrants expired
  (1,023,784) $1.65         
Outstanding, September 30, 2013
  9,441,942  $0. 77   5.09  $9,611,403 
 
During the three months ended September 31, 2013 and 2012, the Company recorded option and warrant expenses of $95,971, and $72,100, respectively. During the nine months ended September 31, 2013 and 2012, the Company recorded option and warrant expenses of $284,371 and $168,000, respectively.